Sterling Pharma Solutions recently announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022. The facility will provide additional capacity for Sterling’s gr...
Sterling Pharma Solutions recently announced it had reached agreement with Novartis to acquire its Ringaskiddy campus (Novartis Ringaskiddy Limited), near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed. Under the terms...
Sterling Pharma Solutions will acquire and operate Novartis Ringaskiddy Limited Pharmaceutical Facility, located in Cork, Ireland This agreement foresees the continued provision of manufacturing, in a number of key areas, like cardiology, immunology, and oncology to Novartis Novartis and Sterling expect ...